Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1993 2
1994 1
2004 1
2005 1
2006 5
2008 7
2009 8
2010 4
2011 3
2012 6
2013 6
2014 3
2015 4
2016 3
2017 5
2018 5
2019 11
2020 10
2021 8
2022 10
2023 10
2024 13
2025 12
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Omalizumab for the Treatment of Multiple Food Allergies.
Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, Leung DYM, Vickery BP, Bird JA, Spergel JM, Iqbal A, Olsson J, Ligueros-Saylan M, Uddin A, Calatroni A, Huckabee CM, Rogers NH, Yovetich N, Dantzer J, Mudd K, Wang J, Groetch M, Pyle D, Keet CA, Kulis M, Sindher SB, Long A, Scurlock AM, Lanser BJ, Lee T, Parrish C, Brown-Whitehorn T, Spergel AKR, Veri M, Hamrah SD, Brittain E, Poyser J, Wheatley LM, Chinthrajah RS. Wood RA, et al. Among authors: shreffler wg. N Engl J Med. 2024 Mar 7;390(10):889-899. doi: 10.1056/NEJMoa2312382. Epub 2024 Feb 25. N Engl J Med. 2024. PMID: 38407394 Free PMC article. Clinical Trial.
AR101 Oral Immunotherapy for Peanut Allergy.
PALISADE Group of Clinical Investigators; Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibáñez MD, Tilles S, Assa’ad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC Jr, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernández-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW. PALISADE Group of Clinical Investigators, et al. Among authors: shreffler wg. N Engl J Med. 2018 Nov 22;379(21):1991-2001. doi: 10.1056/NEJMoa1812856. Epub 2018 Nov 18. N Engl J Med. 2018. PMID: 30449234 Clinical Trial.
Reply.
Ruiter B, Shreffler WG. Ruiter B, et al. Among authors: shreffler wg. J Allergy Clin Immunol. 2022 Jan;149(1):451-452. doi: 10.1016/j.jaci.2021.08.034. Epub 2021 Oct 19. J Allergy Clin Immunol. 2022. PMID: 34674854 No abstract available.
TCF1-LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases.
Kratchmarov R, Djeddi S, Dunlap G, He W, Jia X, Burk CM, Ryan T, McGill A, Allegretti JR, Kataru RP, Mehrara BJ, Taylor EM, Agarwal S, Bhattacharyya N, Bergmark RW, Maxfield AZ, Lee S, Roditi R, Dwyer DF, Boyce JA, Buchheit KM, Laidlaw TM, Shreffler WG, Rao DA, Gutierrez-Arcelus M, Brennan PJ. Kratchmarov R, et al. Among authors: shreffler wg. Nat Immunol. 2024 May;25(5):902-915. doi: 10.1038/s41590-024-01803-2. Epub 2024 Apr 8. Nat Immunol. 2024. PMID: 38589618 Free PMC article.
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study.
Vickery BP, Bird JA, Chinthrajah RS, Jones SM, Keet CA, Kim EH, Leung DYM, Shreffler WG, Sicherer SH, Sindher S, Spergel J, Wood RA. Vickery BP, et al. Among authors: shreffler wg. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2947-2954. doi: 10.1016/j.jaip.2024.08.056. Epub 2024 Sep 16. J Allergy Clin Immunol Pract. 2024. PMID: 39293782 Free PMC article.
Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis.
Sánchez-Martínez E, Rondeau LE, Garrido-Romero M, da Luz BB, Haas DA, Yuen G, Hall P, Dang R, Wang XY, Moreno-Serna L, López-Sanz C, Nuñez-Borque E, Garrido-Arandia M, Diaz-Perales A, Carrasco YR, Koenig JFE, Walker TD, Jordana M, Verdu EF, Surette MG, Ojeda P, Vega F, Blanco C, Shreffler WG, Patil SU, Moreno FJ, Jiménez-Saiz R, Caminero A. Sánchez-Martínez E, et al. Among authors: shreffler wg. bioRxiv [Preprint]. 2025 Feb 19:2025.02.17.638013. doi: 10.1101/2025.02.17.638013. bioRxiv. 2025. Update in: Cell Host Microbe. 2026 Mar 3:S1931-3128(26)00081-8. doi: 10.1016/j.chom.2026.02.013. PMID: 40027733 Free PMC article. Updated. Preprint.
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop.
Rabin RL, Altman MC, Arshad SH, Beger RD, Frischmeyer-Guerrerio PA, Goleva E, Hamilton RG, Khurana Hershey GK, Shamji MH, Sampson HA, Santos AF, Shreffler WG, Togias A, Vieths S, Wambre E, Wenzel SE, Hise K, Lee J, Tripathi A, Slater JE. Rabin RL, et al. Among authors: shreffler wg. J Allergy Clin Immunol. 2025 Jun;155(6):1753-1766. doi: 10.1016/j.jaci.2025.03.014. Epub 2025 Mar 26. J Allergy Clin Immunol. 2025. PMID: 40154576 Free article. Review.
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Anvari S, Berger WE, Bird JA, Chan ES, Chinthrajah RS, Chong HJ, Fineman SM, Fleischer DM, Gonzalez-Reyes E, Kim EH, Lanser BJ, MacGinnitie A, Mehta H, Petroni D, Rupp N, Schneider LC, Scurlock AM, Sher LD, Shreffler WG, Sindher SB, Wood R, Yang WH, Sampson HA, Bois T, Green TD, Campbell DE, Bee KJ, Bégin P. Pongracic JA, et al. Among authors: shreffler wg. J Allergy Clin Immunol Pract. 2025 May;13(5):1190-1200.e3. doi: 10.1016/j.jaip.2025.02.024. Epub 2025 Feb 27. J Allergy Clin Immunol Pract. 2025. PMID: 40023371 Free article. Clinical Trial.
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.
Chinthrajah RS, Sindher SB, Nadeau KC, Leflein JG, Spergel JM, Petroni DH, Jones SM, Casale TB, Wang J, Carr WW, Shreffler WG, Wood RA, Wambre E, Liu J, Akinlade B, Atanasio A, Orengo JM, Hamilton JD, Kamal MA, Hooper AT, Patel K, Laws E, Mannent LP, Adelman DC, Ratnayake A, Radin AR. Chinthrajah RS, et al. Among authors: shreffler wg. Allergy. 2025 Mar;80(3):827-842. doi: 10.1111/all.16420. Epub 2024 Dec 14. Allergy. 2025. PMID: 39673367 Free PMC article. Clinical Trial.
129 results